Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (61-70 of 205) with videos related to

Pageof 21
Sort By:
Plos One|January 18, 2023
Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in FranceLoïg Gaugain, Hélène Cawston, Coline Dubois de Gennes, et al.
Journal of Proteome Research|May 17, 2011
Metabolomic approach by 1H NMR spectroscopy of serum for the assessment of chronic liver failure in patients with cirrhosisRoland Amathieu, Pierre Nahon, Mohamed Triba, et al.
Biomedical Reports|April 18, 2017
Nuclear magnetic resonance metabolomics and human liver diseases: The principles and evidence associated with protein and carbohydrate metabolismLaurence Le Moyec, Mohamed N Triba, Pierre Nahon, et al.
Journal of Hepatology|June 7, 2024
EASL position paper on clinical follow-up after HCV cureThomas Reiberger, Sabela Lens, Giuseppe Cabibbo, et al.
Molecular Biosystems|November 11, 2014
PLS/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parametersMohamed N Triba, Laurence Le Moyec, Roland Amathieu, et al.
Hepatology (Baltimore, Md.)|December 14, 2011
PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosisEric Trepo, Erwan Guyot, Nathalie Ganne-Carrie, et al.
Journal of Liver Cancer|May 14, 2026
Outcomes of Early-Stage HCC patients treated by resection or ablation: real-life data from the French administrative health care database (SNDS)Marie Decraecker, Boris Guiu, Emmanuel Boleslawski, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2024
Hepatitis D Virus Infection Markedly Increases the Risk of Hepatocellular Carcinoma in Patients with Viral B CirrhosisDominique Roulot, Richard Layese, Ségolène Brichler, et al.
Journal of Viral Hepatitis|March 9, 2023
Dynamic personalized prediction of the individual liver-related risk after sustained viral response in HCV patientsClémence Moreau, Marine Roux, Jérémie Riou, et al.
Clinics and Research in Hepatology and Gastroenterology|November 16, 2024
Prolonged survival in women with hepatocellular carcinoma: A French observational studyCécilia Busso, Jean-Charles Nault, Richard Layese, et al.
Pageof 21

Showing results (61-70 of 205) with videos related to

Sort By:
Pageof 21
Plos One|January 18, 2023
Cost-utility analysis of atezolizumab with bevacizumab in untreated unresectable or advanced hepatocellular carcinoma in FranceLoïg Gaugain, Hélène Cawston, Coline Dubois de Gennes, et al.
Journal of Proteome Research|May 17, 2011
Metabolomic approach by 1H NMR spectroscopy of serum for the assessment of chronic liver failure in patients with cirrhosisRoland Amathieu, Pierre Nahon, Mohamed Triba, et al.
Biomedical Reports|April 18, 2017
Nuclear magnetic resonance metabolomics and human liver diseases: The principles and evidence associated with protein and carbohydrate metabolismLaurence Le Moyec, Mohamed N Triba, Pierre Nahon, et al.
Journal of Hepatology|June 7, 2024
EASL position paper on clinical follow-up after HCV cureThomas Reiberger, Sabela Lens, Giuseppe Cabibbo, et al.
Molecular Biosystems|November 11, 2014
PLS/OPLS models in metabolomics: the impact of permutation of dataset rows on the K-fold cross-validation quality parametersMohamed N Triba, Laurence Le Moyec, Roland Amathieu, et al.
Hepatology (Baltimore, Md.)|December 14, 2011
PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosisEric Trepo, Erwan Guyot, Nathalie Ganne-Carrie, et al.
Journal of Liver Cancer|May 14, 2026
Outcomes of Early-Stage HCC patients treated by resection or ablation: real-life data from the French administrative health care database (SNDS)Marie Decraecker, Boris Guiu, Emmanuel Boleslawski, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 26, 2024
Hepatitis D Virus Infection Markedly Increases the Risk of Hepatocellular Carcinoma in Patients with Viral B CirrhosisDominique Roulot, Richard Layese, Ségolène Brichler, et al.
Journal of Viral Hepatitis|March 9, 2023
Dynamic personalized prediction of the individual liver-related risk after sustained viral response in HCV patientsClémence Moreau, Marine Roux, Jérémie Riou, et al.
Clinics and Research in Hepatology and Gastroenterology|November 16, 2024
Prolonged survival in women with hepatocellular carcinoma: A French observational studyCécilia Busso, Jean-Charles Nault, Richard Layese, et al.
Pageof 21